Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITRE III: Influenza B Immunogenicity in Children
NCT03753347Phase 4Active, not recruiting
- Sponsor
- British Columbia Centre for Disease Control
- Start
- Dec 2018
- Primary completion
- Apr 2019
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of influenza virus quadrivalent inactivated vaccine in influenza, sponsored by British Columbia Centre for Disease Control. Started Dec 2018; status: active, not recruiting.
02
Drugs
influenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03753347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03753347.